首页 > 最新文献

Revista española de cardiología (English ed.)最新文献

英文 中文
Cardiogenic shock complicating acute myocardial infarction and multivessel disease: revascularization strategy according to ischemic territory 急性心肌梗死和多血管疾病并发的心源性休克:根据缺血部位制定血管再通策略。
IF 7.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-02-01 DOI: 10.1016/j.rec.2024.05.005
Ki Hong Choi , Sang Yoon Lee , Taek Kyu Park , Joo Myung Lee , Young Bin Song , Joo-Yong Hahn , Seung-Hyuk Choi , Chul-Min Ahn , Cheol Woong Yu , Ik Hyun Park , Woo Jin Jang , Hyun-Joong Kim , Jang-Whan Bae , Sung Uk Kwon , Hyun-Jong Lee , Wang Soo Lee , Jin-Ok Jeong , Sang-Don Park , Tae-Soo Kang , Hyeon-Cheol Gwon , Jeong Hoon Yang

Introduction and objectives

The association of revascularization strategy with clinical outcomes according to the ischemic territory of nonculprit lesion has not been documented in patients with acute myocardial infarction complicated by cardiogenic shock (AMI-CS). This study aimed to compare outcomes between culprit-only and immediate multivessel percutaneous coronary intervention (PCI) according to ischemic territory in patients with AMI-CS.

Methods

A total of 536 patients with AMI-CS and multivessel disease from the SMART-RESCUE registry were categorized according to ischemic territory (nonculprit left main/proximal left anterior descending artery [LM/pLAD] vs culprit LM/pLAD vs no LM/pLAD). The primary outcome was a patient-oriented composite endpoint (POCE) consisting of all-cause death, myocardial infarction, rehospitalization due to heart failure, or repeat revascularization at 1 year.

Results

Among the total population, 108 patients had nonculprit LM/pLAD, 228 patients had culprit LM/pLAD, and 200 patients had no LM/pLAD, with the risk of POCE being higher in patients with large ischemic territory lesions (53.6% vs 53.4% vs 39.6%; P = .02). Multivessel PCI was associated with a significantly lower risk of POCE compared with culprit-only PCI in patients with nonculprit LM/pLAD (40.7% vs 66.9%; HR, 0.52; 95%CI, 0.29-0.91; P = .02), but not in those with culprit LM/pLAD (P = .46) or no LM/pLAD (P = .47). A significant interaction existed between revascularization strategy and large nonculprit ischemic territory (P = .03).

Conclusions

Large ischemic territory involvement was associated with worse clinical outcomes in patients with AMI-CS and multivessel disease. Immediate multivessel PCI might improve clinical outcomes in patients with a large nonculprit ischemic burden.
引言和目的:在急性心肌梗死并发心源性休克(AMI-CS)患者中,根据非罪魁祸首病变的缺血区域确定血管再通策略与临床预后的关系尚未得到证实。本研究旨在根据急性心肌梗死并发心源性休克(AMI-CS)患者的缺血区域,比较单纯罪魁祸首和即刻多血管经皮冠状动脉介入治疗(PCI)的疗效:共有536名AMI-CS和多支血管疾病患者来自SMART-RESCUE登记处,根据缺血部位进行分类(无左主干/近端左前降支[LM/pLAD] vs 有左主干/pLAD vs 无左主干/pLAD)。主要结果是以患者为导向的复合终点(POCE),包括全因死亡、心肌梗死、因心力衰竭再次住院或一年后再次接受血管重建:在所有患者中,108 名患者为非致命性 LM/pLAD,228 名患者为致命性 LM/pLAD,200 名患者无 LM/pLAD,缺血区域病变较大的患者发生 POCE 的风险更高(53.6% vs 53.4% vs 39.6%;P = .02)。与单纯罪魁祸首 PCI 相比,多血管 PCI 与非罪魁祸首 LM/pLAD 患者的 POCE 风险显著降低相关(40.7% vs 66.9%;HR,0.52;95%CI,0.29-0.91;P = .02),但与罪魁祸首 LM/pLAD 患者(P = .46)或无 LM/pLAD 患者(P = .47)无关。血管再通策略与大面积非罪魁祸首缺血区域之间存在明显的交互作用(P = .03):结论:对于AMI-CS和多支血管疾病患者,大面积缺血区域受累与较差的临床预后有关。立即进行多血管 PCI 可改善大面积非微血管缺血患者的临床预后。
{"title":"Cardiogenic shock complicating acute myocardial infarction and multivessel disease: revascularization strategy according to ischemic territory","authors":"Ki Hong Choi ,&nbsp;Sang Yoon Lee ,&nbsp;Taek Kyu Park ,&nbsp;Joo Myung Lee ,&nbsp;Young Bin Song ,&nbsp;Joo-Yong Hahn ,&nbsp;Seung-Hyuk Choi ,&nbsp;Chul-Min Ahn ,&nbsp;Cheol Woong Yu ,&nbsp;Ik Hyun Park ,&nbsp;Woo Jin Jang ,&nbsp;Hyun-Joong Kim ,&nbsp;Jang-Whan Bae ,&nbsp;Sung Uk Kwon ,&nbsp;Hyun-Jong Lee ,&nbsp;Wang Soo Lee ,&nbsp;Jin-Ok Jeong ,&nbsp;Sang-Don Park ,&nbsp;Tae-Soo Kang ,&nbsp;Hyeon-Cheol Gwon ,&nbsp;Jeong Hoon Yang","doi":"10.1016/j.rec.2024.05.005","DOIUrl":"10.1016/j.rec.2024.05.005","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>The association of revascularization strategy with clinical outcomes according to the ischemic territory of nonculprit lesion has not been documented in patients with acute myocardial infarction complicated by cardiogenic shock (AMI-CS). This study aimed to compare outcomes between culprit-only and immediate multivessel percutaneous coronary intervention (PCI) according to ischemic territory in patients with AMI-CS.</div></div><div><h3>Methods</h3><div>A total of 536 patients with AMI-CS and multivessel disease from the SMART-RESCUE registry were categorized according to ischemic territory (nonculprit left main/proximal left anterior descending artery [LM/pLAD] vs culprit LM/pLAD vs no LM/pLAD). The primary outcome was a patient-oriented composite endpoint (POCE) consisting of all-cause death, myocardial infarction, rehospitalization due to heart failure, or repeat revascularization at 1 year.</div></div><div><h3>Results</h3><div>Among the total population, 108 patients had nonculprit LM/pLAD, 228 patients had culprit LM/pLAD, and 200 patients had no LM/pLAD, with the risk of POCE being higher in patients with large ischemic territory lesions (53.6% vs 53.4% vs 39.6%; <em>P</em> = .02). Multivessel PCI was associated with a significantly lower risk of POCE compared with culprit-only PCI in patients with nonculprit LM/pLAD (40.7% vs 66.9%; HR, 0.52; 95%CI, 0.29-0.91; <em>P<!--> </em>=<!--> <!-->.02), but not in those with culprit LM/pLAD (<em>P<!--> </em>=<!--> <!-->.46) or no LM/pLAD (<em>P<!--> </em>=<!--> <!-->.47). A significant interaction existed between revascularization strategy and large nonculprit ischemic territory (<em>P<!--> </em>=<!--> <!-->.03).</div></div><div><h3>Conclusions</h3><div>Large ischemic territory involvement was associated with worse clinical outcomes in patients with AMI-CS and multivessel disease. Immediate multivessel PCI might improve clinical outcomes in patients with a large nonculprit ischemic burden.</div></div>","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":"78 2","pages":"Pages 97-106"},"PeriodicalIF":7.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141180661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P-wave characteristics during pulmonary vein pacing to guide localization of transient reconnections unmasked by adenosine administration 肺静脉起搏时的 P 波特征,用于指导定位因服用腺苷而未被掩盖的瞬时再连接。
IF 7.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-02-01 DOI: 10.1016/j.rec.2024.08.016
Daniel Cantero Lozano , Isabel Cornejo Mazzuchelli , Paloma Lapunzina Soler , M. Teresa Barrio-López , Eduardo Castellanos Martínez , Jesús Almendral
{"title":"P-wave characteristics during pulmonary vein pacing to guide localization of transient reconnections unmasked by adenosine administration","authors":"Daniel Cantero Lozano ,&nbsp;Isabel Cornejo Mazzuchelli ,&nbsp;Paloma Lapunzina Soler ,&nbsp;M. Teresa Barrio-López ,&nbsp;Eduardo Castellanos Martínez ,&nbsp;Jesús Almendral","doi":"10.1016/j.rec.2024.08.016","DOIUrl":"10.1016/j.rec.2024.08.016","url":null,"abstract":"","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":"78 2","pages":"Pages 153-156"},"PeriodicalIF":7.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142569783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of transcatheter edge-to-edge repair for cardiac implantable electronic device-associated tricuspid regurgitation: insights from the TRI-SPA registry.
IF 7.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-31 DOI: 10.1016/j.rec.2025.01.010
Andrea Ruberti, Pedro Cepas-Guillén, Julio Echarte-Morales, Dabit Arzamendi, Vanessa Moñivas, Fernando Carrasco-Chinchilla, Manuel Pan, Luis Nombela-Franco, Isaac Pascual, Claudio E Guerreiro, Tomás Benito-González, Ruth Pérez, Iván Gómez-Blázquez, Ignacio J Amat-Santos, Eduardo Flores-Umanzor, Ignacio Cruz-González, Ángel Sánchez-Recalde, Ana Belén Cid Álvarez, Manuel Barreiro-Pérez, Laura Sanchis, Chi-Hion Li, Berenice Caneiro-Queija, María Del Trigo, José David Martínez-Carmona, Dolores Mesa, Pilar Jiménez Quevedo, Pablo Avanzas, Rodrigo Estévez-Loureiro, Xavier Freixa

Introduction and objectives: This study aimed to assess the effectiveness and clinical outcomes of tricuspid transcatheter edge-to-edge repair (T-TEER) in patients with cardiac implantable electronic devices (CIEDs).

Methods: This subanalysis of the Transcatheter Tricuspid Valve Repair in Spain (TRI-SPA) registry included patients with at least severe tricuspid regurgitation (TR) who were treated with T-TEER between June 2020 and May 2023 in Spain. Patients with CIEDs and no or mild tricuspid lead-leaflet interaction were compared with those without CIEDs. The primary composite endpoint was all-cause mortality, heart failure-related hospitalization, and tricuspid valve reintervention at 12 months.

Results: Among 310 patients (mean age 75.5 ± 9.1 years, 70% female) with significant TR treated with T-TEER, 35 (11%) had CIEDs. Device implantation success was high in both groups (97.1% in the CIED group vs 96.4% in the non-CIED group, P = .81), with a similar rate of ≤ 2+ residual TR (84.9% in the CIED group vs 91.0% in the non-CIED group, P = .26). Patients with CIEDs experienced comparable rates of the primary composite endpoint to the non-CIED group (23.8% vs 19.1%, respectively, HR, 1.40; 95%CI, 0.60-3.31; P = .44), sustained successful TR reduction (≤ 2+ in 55.0% vs 73.8%, P = .07), and functional improvement (NYHA class I/II 81.8% vs 79.9%, P = .79).

Conclusions: In a real-world setting, T-TEER seems to be an effective therapeutic option for selected patients with more than moderate TR and CIEDs with no or mild lead-leaflet interaction, offering comparable cardiovascular outcomes and clinical improvement to those without leads. However, the presence of CIEDs may represent an independent risk factor for TR recurrence.

{"title":"Efficacy of transcatheter edge-to-edge repair for cardiac implantable electronic device-associated tricuspid regurgitation: insights from the TRI-SPA registry.","authors":"Andrea Ruberti, Pedro Cepas-Guillén, Julio Echarte-Morales, Dabit Arzamendi, Vanessa Moñivas, Fernando Carrasco-Chinchilla, Manuel Pan, Luis Nombela-Franco, Isaac Pascual, Claudio E Guerreiro, Tomás Benito-González, Ruth Pérez, Iván Gómez-Blázquez, Ignacio J Amat-Santos, Eduardo Flores-Umanzor, Ignacio Cruz-González, Ángel Sánchez-Recalde, Ana Belén Cid Álvarez, Manuel Barreiro-Pérez, Laura Sanchis, Chi-Hion Li, Berenice Caneiro-Queija, María Del Trigo, José David Martínez-Carmona, Dolores Mesa, Pilar Jiménez Quevedo, Pablo Avanzas, Rodrigo Estévez-Loureiro, Xavier Freixa","doi":"10.1016/j.rec.2025.01.010","DOIUrl":"https://doi.org/10.1016/j.rec.2025.01.010","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>This study aimed to assess the effectiveness and clinical outcomes of tricuspid transcatheter edge-to-edge repair (T-TEER) in patients with cardiac implantable electronic devices (CIEDs).</p><p><strong>Methods: </strong>This subanalysis of the Transcatheter Tricuspid Valve Repair in Spain (TRI-SPA) registry included patients with at least severe tricuspid regurgitation (TR) who were treated with T-TEER between June 2020 and May 2023 in Spain. Patients with CIEDs and no or mild tricuspid lead-leaflet interaction were compared with those without CIEDs. The primary composite endpoint was all-cause mortality, heart failure-related hospitalization, and tricuspid valve reintervention at 12 months.</p><p><strong>Results: </strong>Among 310 patients (mean age 75.5 ± 9.1 years, 70% female) with significant TR treated with T-TEER, 35 (11%) had CIEDs. Device implantation success was high in both groups (97.1% in the CIED group vs 96.4% in the non-CIED group, P = .81), with a similar rate of ≤ 2+ residual TR (84.9% in the CIED group vs 91.0% in the non-CIED group, P = .26). Patients with CIEDs experienced comparable rates of the primary composite endpoint to the non-CIED group (23.8% vs 19.1%, respectively, HR, 1.40; 95%CI, 0.60-3.31; P = .44), sustained successful TR reduction (≤ 2+ in 55.0% vs 73.8%, P = .07), and functional improvement (NYHA class I/II 81.8% vs 79.9%, P = .79).</p><p><strong>Conclusions: </strong>In a real-world setting, T-TEER seems to be an effective therapeutic option for selected patients with more than moderate TR and CIEDs with no or mild lead-leaflet interaction, offering comparable cardiovascular outcomes and clinical improvement to those without leads. However, the presence of CIEDs may represent an independent risk factor for TR recurrence.</p>","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":" ","pages":""},"PeriodicalIF":7.2,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143081009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Apical sparing during exercise echocardiography for suspected cardiac amyloidosis.
IF 7.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-31 DOI: 10.1016/j.rec.2025.01.009
Jesús Peteiro, Marina Combarro, Gonzalo Barge-Caballero, Alberto Bouzas-Mosquera, José Larrañaga-Moreira, José M Vázquez-Rodríguez
{"title":"Apical sparing during exercise echocardiography for suspected cardiac amyloidosis.","authors":"Jesús Peteiro, Marina Combarro, Gonzalo Barge-Caballero, Alberto Bouzas-Mosquera, José Larrañaga-Moreira, José M Vázquez-Rodríguez","doi":"10.1016/j.rec.2025.01.009","DOIUrl":"10.1016/j.rec.2025.01.009","url":null,"abstract":"","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":" ","pages":""},"PeriodicalIF":7.2,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143080770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Left atrial appendage occlusion in patients with atrial fibrillation and cancer. Short- and mid-term outcomes.
IF 7.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-28 DOI: 10.1016/j.rec.2024.12.013
Sergio López-Tejero, Pablo Antúnez-Muiños, Miguel Hernández-Hidalgo, Ana Martín-García, Pedro L Sánchez-Fernández, Ignacio Cruz-González
{"title":"Left atrial appendage occlusion in patients with atrial fibrillation and cancer. Short- and mid-term outcomes.","authors":"Sergio López-Tejero, Pablo Antúnez-Muiños, Miguel Hernández-Hidalgo, Ana Martín-García, Pedro L Sánchez-Fernández, Ignacio Cruz-González","doi":"10.1016/j.rec.2024.12.013","DOIUrl":"10.1016/j.rec.2024.12.013","url":null,"abstract":"","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":" ","pages":""},"PeriodicalIF":7.2,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143068475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical association of the SCN5A c.2302A>G variant (p.Ile768Val) with Brugada syndrome.
IF 7.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-28 DOI: 10.1016/j.rec.2024.12.014
Boris Kuzmicic Calderón, Bernardita Martínez Galdames, Mario Hassi Thumala, Jorge Van Grieken, Jovan Kuzmicic
{"title":"Clinical association of the SCN5A c.2302A>G variant (p.Ile768Val) with Brugada syndrome.","authors":"Boris Kuzmicic Calderón, Bernardita Martínez Galdames, Mario Hassi Thumala, Jorge Van Grieken, Jovan Kuzmicic","doi":"10.1016/j.rec.2024.12.014","DOIUrl":"10.1016/j.rec.2024.12.014","url":null,"abstract":"","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":" ","pages":""},"PeriodicalIF":7.2,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143068470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for the progression of aortic regurgitation following surgical repair of sinus of Valsalva aneurysms. Analysis of 317 cases.
IF 7.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-27 DOI: 10.1016/j.rec.2025.01.004
Tianyu Chen, Jianzheng Cen, Shusheng Wen, Jimei Chen, Jian Zhuang, Xiaobing Liu
{"title":"Risk factors for the progression of aortic regurgitation following surgical repair of sinus of Valsalva aneurysms. Analysis of 317 cases.","authors":"Tianyu Chen, Jianzheng Cen, Shusheng Wen, Jimei Chen, Jian Zhuang, Xiaobing Liu","doi":"10.1016/j.rec.2025.01.004","DOIUrl":"10.1016/j.rec.2025.01.004","url":null,"abstract":"","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":" ","pages":""},"PeriodicalIF":7.2,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143048147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary and secondary cardiovascular prevention through life cycles in women. Consensus document of the SEC-GT CVD in Women, ACP-SEC, SEGO, AEEM, SEEN, semFYC, SEMERGEN, AEP, and AEM.
IF 7.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-25 DOI: 10.1016/j.rec.2025.01.005
Antonia Sambola, Raquel Campuzano, Almudena Castro, María Goya, Pluvio Coronado, Rosa Fernández-Olmo, Miguel Ángel María-Tablado, Carolina Ortiz-Cortés, Xènia Ortolà, Vicente Pallarés-Carratalá, Antonia Pijuan-Domenech, Rosa M Plata, Rosa María Sánchez-Hernández, José Manuel Siurana, Càtia Timoteo, Begoña Viejo-Hernández

This consensus document on cardiovascular disease in women summarizes the views of a panel of experts organized by the Working Group on Women and Cardiovascular Disease of the Spanish Society of Cardiology (SEC-GT CVD in Women), and the Association of Preventive Cardiology of the SEC (ACP-SEC). The document was developed in collaboration with experts from various Spanish societies and associations: the Spanish Society of Gynecology and Obstetrics (SEGO), the Spanish Society of Endocrinology and Nutrition (SEEN), the Spanish Association for the Study of Menopause (AEEM), the Spanish Association of Pediatrics (AEP), the Spanish Society of Primary Care Physicians (SEMERGEN), the Spanish Society of Family and Community Medicine (semFYC), and the Spanish Association of Midwives (AEM). The document received formal approval from the SEC. This consensus serves as a guide for the clinical community on the diagnostic approach and management of cardiovascular health during the stages or life cycles of women: adolescence, the menopausal transition, postpartum disorders, and other gynecologic conditions. It is based on current evidence and best available practices.

{"title":"Primary and secondary cardiovascular prevention through life cycles in women. Consensus document of the SEC-GT CVD in Women, ACP-SEC, SEGO, AEEM, SEEN, semFYC, SEMERGEN, AEP, and AEM.","authors":"Antonia Sambola, Raquel Campuzano, Almudena Castro, María Goya, Pluvio Coronado, Rosa Fernández-Olmo, Miguel Ángel María-Tablado, Carolina Ortiz-Cortés, Xènia Ortolà, Vicente Pallarés-Carratalá, Antonia Pijuan-Domenech, Rosa M Plata, Rosa María Sánchez-Hernández, José Manuel Siurana, Càtia Timoteo, Begoña Viejo-Hernández","doi":"10.1016/j.rec.2025.01.005","DOIUrl":"10.1016/j.rec.2025.01.005","url":null,"abstract":"<p><p>This consensus document on cardiovascular disease in women summarizes the views of a panel of experts organized by the Working Group on Women and Cardiovascular Disease of the Spanish Society of Cardiology (SEC-GT CVD in Women), and the Association of Preventive Cardiology of the SEC (ACP-SEC). The document was developed in collaboration with experts from various Spanish societies and associations: the Spanish Society of Gynecology and Obstetrics (SEGO), the Spanish Society of Endocrinology and Nutrition (SEEN), the Spanish Association for the Study of Menopause (AEEM), the Spanish Association of Pediatrics (AEP), the Spanish Society of Primary Care Physicians (SEMERGEN), the Spanish Society of Family and Community Medicine (semFYC), and the Spanish Association of Midwives (AEM). The document received formal approval from the SEC. This consensus serves as a guide for the clinical community on the diagnostic approach and management of cardiovascular health during the stages or life cycles of women: adolescence, the menopausal transition, postpartum disorders, and other gynecologic conditions. It is based on current evidence and best available practices.</p>","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":" ","pages":""},"PeriodicalIF":7.2,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143053754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infective endocarditis: a growing threat despite medical progress. A look at trends in Spain.
IF 7.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-25 DOI: 10.1016/j.rec.2025.01.006
Lucía Cayuela, Pablo Del Valle Loarte, Beatriz Valle Borrego, Aurelio Cayuela

Introduction and objectives: Infective endocarditis (IE) is a serious public health problem both in Spain and worldwide. This study aimed to analyze the trends in the incidence of IE in Spain from 1992 to 2021.

Methods: We used IE incidence data from the Global Health Data Exchange and population data from the Spanish National Statistics Institute to analyze changes in age-standardized incidence rates. Joinpoint and Age-Period-Cohort (A-P-C) models were applied to identify significant trend changes and the effects of age, period, and birth cohort.

Results: The age-standardized incidence rates of IE increased from 17.5 cases per 100 000 population in 1992 to 30.8 per 100,000 in 2021 among men and from 16.8 per 100 000 in 1992 to 22.9 per 100 000 in 2021 among women. Joinpoint analysis revealed distinct trend changes, with men having a faster rate of increase (1.9%) compared with women (1.1%). The male-to-female incidence rate ratio peaked at 1.4, indicating a higher risk of IE among men. The incidence of IE was significantly influenced by age, period, and cohort. Both sexes showed increasing risk with age. Risk increased in women born in the late 20th and early 21st centuries compared with earlier cohorts. Men in these later cohorts showed a decreasing risk. Period effects increased from the 1990s to the mid-2000s and then declined, especially among men.

Conclusions: This study reveals a significant increase in the incidence of IE in Spain, especially among older adults and men. These trends reflect demographic changes, medical advances, and changing risk factors.

{"title":"Infective endocarditis: a growing threat despite medical progress. A look at trends in Spain.","authors":"Lucía Cayuela, Pablo Del Valle Loarte, Beatriz Valle Borrego, Aurelio Cayuela","doi":"10.1016/j.rec.2025.01.006","DOIUrl":"10.1016/j.rec.2025.01.006","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Infective endocarditis (IE) is a serious public health problem both in Spain and worldwide. This study aimed to analyze the trends in the incidence of IE in Spain from 1992 to 2021.</p><p><strong>Methods: </strong>We used IE incidence data from the Global Health Data Exchange and population data from the Spanish National Statistics Institute to analyze changes in age-standardized incidence rates. Joinpoint and Age-Period-Cohort (A-P-C) models were applied to identify significant trend changes and the effects of age, period, and birth cohort.</p><p><strong>Results: </strong>The age-standardized incidence rates of IE increased from 17.5 cases per 100 000 population in 1992 to 30.8 per 100,000 in 2021 among men and from 16.8 per 100 000 in 1992 to 22.9 per 100 000 in 2021 among women. Joinpoint analysis revealed distinct trend changes, with men having a faster rate of increase (1.9%) compared with women (1.1%). The male-to-female incidence rate ratio peaked at 1.4, indicating a higher risk of IE among men. The incidence of IE was significantly influenced by age, period, and cohort. Both sexes showed increasing risk with age. Risk increased in women born in the late 20th and early 21st centuries compared with earlier cohorts. Men in these later cohorts showed a decreasing risk. Period effects increased from the 1990s to the mid-2000s and then declined, especially among men.</p><p><strong>Conclusions: </strong>This study reveals a significant increase in the incidence of IE in Spain, especially among older adults and men. These trends reflect demographic changes, medical advances, and changing risk factors.</p>","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":" ","pages":""},"PeriodicalIF":7.2,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143053746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mediterranean diet intervention and coronary plaque progression after acute coronary syndrome. The MEDIMACS clinical trial. 地中海饮食干预与急性冠状动脉综合征后冠状动脉斑块的进展。MEDIMACS 临床试验。
IF 7.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-25 DOI: 10.1016/j.rec.2025.01.008
Ana I Fernández-Ávila, Enrique Gutiérrez-Ibañes, Álvaro Gabaldón, Josep Gómez-Lara, Miguel Ángel Martínez-González, Javier Bermejo, Irene Martín de Miguel, Ricardo Sanz-Ruiz, Elena Jurado, Francisco Fernández-Avilés, Cristina Razquin Burillo, Rafael de la Torre, Pablo Martínez-Legazpi, Raquel Yotti, Alex Mira, Uri Gophna, Roger Karlsson, Reem Al-Daccak, Dominique Charron
{"title":"Mediterranean diet intervention and coronary plaque progression after acute coronary syndrome. The MEDIMACS clinical trial.","authors":"Ana I Fernández-Ávila, Enrique Gutiérrez-Ibañes, Álvaro Gabaldón, Josep Gómez-Lara, Miguel Ángel Martínez-González, Javier Bermejo, Irene Martín de Miguel, Ricardo Sanz-Ruiz, Elena Jurado, Francisco Fernández-Avilés, Cristina Razquin Burillo, Rafael de la Torre, Pablo Martínez-Legazpi, Raquel Yotti, Alex Mira, Uri Gophna, Roger Karlsson, Reem Al-Daccak, Dominique Charron","doi":"10.1016/j.rec.2025.01.008","DOIUrl":"10.1016/j.rec.2025.01.008","url":null,"abstract":"","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":" ","pages":""},"PeriodicalIF":7.2,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143053747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista española de cardiología (English ed.)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1